Diomics and Bonne Santé Group announced today that they entered into a strategic alliance to develop a line of Diocare products.
San Diego-based Diomics and Miami-based Bonne Santé Group, which operated through its Bonne Santé Natural Manufacturing division, entered the agreement in an effor tto develop, launch and distribute the Diocare products formulated to address the COVID-19 pandemic, according to a news release.
Diomics’ product line includes Diocare nasal biome defense spray, Diocare dual IgG/IgA respiratory immunity capsules, Diocare week1 interferon support drink mix, Diocare cough relief and immune health syrup, Diocare cough relief and immune health soft chews and the Diocare anti-fatigue and neuroprotective symptom relief capsules.
“The Diocare product line is our best of nature response to supporting people around the world as they seek protective, symptom support and recovery strategies as we all make our way through this pandemic together,” Diomics CMO Bill Shepard said in the release.
“We are extraordinarily pleased that Diomics chose Bonne Santé to be its partner in the development and rollout of Diocare™,” added Bonne Santé CEO Ryan Zackon. “There could not be a more important and relevant product brought to market given the world we are now living in. Bonne Santé Natural Manufacturing prides itself on the provision of our world-class services ranging from formulation and manufacturing to supply chain as a service as we bring Diocare to market.”
